Cargando…

Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy

Azacitidine (AZA) is a DNA methyltransferase inhibitor and epigenetic modulator that can be an effective agent in combination with chemotherapy for patients with high‐risk acute myeloid leukemia (AML). However, biological factors driving the therapeutic response of such hypomethylating agent (HMA)‐b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Guanghao, Wang, Linchen, You, Qiancheng, Cahill, Kirk, Chen, Chuanyuan, Zhang, Wei, Fulton, Noreen, Stock, Wendy, Odenike, Olatoyosi, He, Chuan, Han, Dali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427370/ https://www.ncbi.nlm.nih.gov/pubmed/37271891 http://dx.doi.org/10.1002/advs.202300445

Ejemplares similares

Global DNA 5hmC and CK19(5hmC+) Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
por: Jiang, Jinhua, et al.
Publicado: (2021)

Exploring role of 5hmC as potential marker of chemoresistance
por: Kharat, Suhas S., et al.
Publicado: (2020)

TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
por: Lio, Chan-Wang J., et al.
Publicado: (2019)

Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
por: Stöger, Reinhard, et al.
Publicado: (2017)

New Insights into 5hmC DNA Modification: Generation, Distribution and Function
por: Shi, Dong-Qiao, et al.
Publicado: (2017)

5hmC modification regulates R-loop accumulation in response to stress
por: Xu, Xingyun, et al.
Publicado: (2023)

Analysis of archaic human haplotypes suggests that 5hmC acts as an epigenetic guide for NCO recombination
por: Lee, Bernett, et al.
Publicado: (2022)

Crystal structure of the 5hmC specific endonuclease PvuRts1I
por: Kazrani, Asgar Abbas, et al.
Publicado: (2014)

De novo DNA methylation drives 5hmC accumulation in mouse zygotes
por: Amouroux, Rachel, et al.
Publicado: (2016)

Alterations in the Genomic Distribution of 5hmC in In Vivo Aged Human Skin Fibroblasts
por: Kołodziej-Wojnar, Paulina, et al.
Publicado: (2020)

5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary
por: Khare, Tarang, et al.
Publicado: (2012)

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
por: Saliba, Antoine N., et al.
Publicado: (2022)

Standardized Computer-Assisted Analysis of 5-hmC Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
por: Koch, Elias A. T., et al.
Publicado: (2023)

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms
por: Seethy, Ashikh A., et al.
Publicado: (2023)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis
por: Guo, Xiao-Jun, et al.
Publicado: (2023)

Combined methylation mapping of 5mC and 5hmC during early embryonic stages in bovine
por: de Montera, Béatrice, et al.
Publicado: (2013)

A Comparative Study on 5hmC Targeting Regulation of Neurons in AD Mice by Several Natural Compounds
por: Cao, Dongyi, et al.
Publicado: (2020)

Supplemental Herbal Choline Increases 5-hmC DNA on Whole Blood from Pregnant Ewes and Offspring
por: Roque-Jiménez, José Alejandro, et al.
Publicado: (2020)

Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers
por: Wang, Zhihui, et al.
Publicado: (2020)

TET2 Promotes Keloid Hyperplasia by Regulating 5hmC Modification in the TGFβ Promoter Region
por: Niu, Changying, et al.
Publicado: (2023)

5mC and 5hmC dynamics during PGC reprogramming and role of Tet1 in female meiosis
por: Yamaguchi, Shinpei, et al.
Publicado: (2013)

IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC
por: Xu, Qiang, et al.
Publicado: (2016)

Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC)
por: Chu, Yajing, et al.
Publicado: (2018)

iRNA5hmC: The First Predictor to Identify RNA 5-Hydroxymethylcytosine Modifications Using Machine Learning
por: Liu, Yuan, et al.
Publicado: (2020)

Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion
por: Zhang, Zijing, et al.
Publicado: (2019)

β2SP/TET2 complex regulates gene 5hmC modification after cerebral ischemia
por: Ma, Xiaohua, et al.
Publicado: (2021)

5-Hydroxymethylcytosine (5hmC) at or near cancer mutation hot spots as potential targets for early cancer detection
por: Lu, Michael J., et al.
Publicado: (2022)

TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer
por: Chi, Jiadong, et al.
Publicado: (2022)

Genome-wide 5-hydroxymethylcytosine (5hmC) reassigned in Pten-depleted mESCs along neural differentiation
por: Wang, Zhangting, et al.
Publicado: (2022)

Social defeat stress induces genome-wide 5mC and 5hmC alterations in the mouse brain
por: Kuehner, Janise N, et al.
Publicado: (2023)

Analysis of the machinery and intermediates of the 5hmC-mediated DNA demethylation pathway in aging on samples from the MARK-AGE Study
por: Valentini, Elisabetta, et al.
Publicado: (2016)

Species-Specific 5 mC and 5 hmC Genomic Landscapes Indicate Epigenetic Contribution to Human Brain Evolution
por: Madrid, Andy, et al.
Publicado: (2018)

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
por: Kristensen, Gitte, et al.
Publicado: (2019)

Genome-wide 5-hydroxymethylcytosine (5hmC) emerges at early stage of in vitro differentiation of a putative hepatocyte progenitor
por: Rodríguez-Aguilera, Jesús Rafael, et al.
Publicado: (2020)

Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns
por: Adam, Sabrina, et al.
Publicado: (2022)

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
por: Liu, Hongtao, et al.
Publicado: (2018)

Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies
por: Pettit, Kristen, et al.
Publicado: (2015)

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015)

HPV infection and 5mC/5hmC epigenetic markers in penile squamous cell carcinoma: new insights into prognostics
por: Santos, Renan da Silva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7p3qnl8ri3guk34q0irs5tokr3